Prognostic value of gamma‐interferon‐inducible lysosomal thiol reductase expression in female patients diagnosed with breast cancer-Reference-Cited by-同舟云学术

Prognostic value of gamma‐interferon‐inducible lysosomal thiol reductase expression in female patients diagnosed with breast cancer

Published:2021-10-25 Issue:4 Volume:150 Page:705-717
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Ye Chunmiao¹²,Zhou Wenzhong²³⁴,Wang Fei²³⁴,Yin Gengshen¹²,Zhang Xiaoxia⁵,Kong Lingyu⁶,Gao Zhongcheng⁵,Feng Man⁷,Zhou Chengjun⁸,Sun Dianshui⁹,Wang Lei¹⁰,Liu Liyuan²³⁴,Zheng Chao²³⁴,Xiang Yujuan²³⁴,Guo Mingming²³⁴,Huang Shuya¹²³⁴,Yu Zhigang²³⁴^ORCID

Affiliation:

1. School of Medicine, Cheeloo College of Medicine Shandong University Jinan China

2. Department of Breast Surgery The Second Hospital, Cheeloo College of Medicine, Shandong University Jinan China

3. Institute of Translational Medicine of Breast Disease Prevention and Treatment Shandong University Jinan China

4. Shandong Provincial Engineering Laboratory of Translational Research on Prevention and Treatment of Breast Disease The Second Hospital, Cheeloo College of Medicine, Shandong University Jinan China

5. Department of Thyroid and Breast Surgery Linyi People's Hospital Linyi China

6. Department of Breast Surgery Linyi Cancer Hospital Linyi China

7. Department of Pathology The Third Affiliated Hospital of Shandong First Medical University Jinan China

8. Department of Pathology The Second Hospital, Cheeloo College of Medicine, Shandong University Jinan China

9. Cancer Center The Second Hospital, Cheeloo College of Medicine, Shandong University Jinan China

10. Department of Oncology Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33843

Reference35 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer incidence and mortality in China, 2014

3. Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version);National Health Commission of the People's Republic of China;Chin J Cancer Res,2019

4. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012

5. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transcriptional Induction of the Antiviral Host Factor GILT/IFI30 by Interferon Gamma;International Journal of Molecular Sciences;2024-09-06

2. Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers;Cellular Oncology;2024-08-14

3. IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer;International Immunopharmacology;2024-05

4. Potential biomarkers and drug targets in glycoproteome of MCF-7 breast cancer cells based on proteomics and bioinformatics strategies Running title: Protein drug targets in MCF-7 cell line;2024-01-23

5. Pyrotinib is effective in both trastuzumab-sensitive and primary resistant HER2-positive breast tumors;Chinese Journal of Cancer Research;2024